LONN:SWX
Lonza Group AG
CHF 661.60
arrow_upward
+1.44%(+9.40) 1D
Nov 4, 5:31:16 PM GMT+1 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LONN...
Open
CHF 654.00
High
CHF 666.20
Low
CHF 648.80
Mkt. cap
46.46B
Avg. vol.
132.01K
Volume
196.88K
Dividend
0.76%
Quarterly dividend
CHF 1.25
Ex-dividend date
May 12, 2026
52-wk high
CHF 666.20
52-wk low
CHF 454.60
EPS
-CHF 1.57
Shares outstanding
70.23M
No. of employees
20K
Open
CHF 654.00
High
CHF 666.20
Low
CHF 648.80
Mkt. cap
46.46B
Avg. vol.
132.01K
Volume
196.88K
Dividend
0.76%
Quarterly dividend
CHF 1.25
Ex-dividend date
May 12, 2026
52-wk high
CHF 666.20
52-wk low
CHF 454.60
EPS
-CHF 1.57
Shares outstanding
70.23M
No. of employees
20K
News stories
From web sources and news partners
European Pharmaceutical Review
·
9 hours ago
Merck to divest CDMO business across five US sites to Lonza
Chemical & Engineering News
·
22 hours ago
Lonza to buy Merck KGaA’s contract manufacturing business
Fierce Pharma
·
1 day ago
Lonza bets big on US growth, snaps up Merck KGaA’s CDMO business
CHEManager
·
1 day ago
Merck Sells Its CDMO Business to Lonza
Profile
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector. Wikipedia
About Lonza Group AG
CEOWolfgang Wienand
Employees20.1K
Founded1897
HeadquartersBasel, Basel City, Switzerland
SectorHealth care
Industry-
Websitelonza.com